ask="14.98"
ask_size="200"
average_daily_volume="1902940"
bid="9.12"
bid_size="200"
book_value="-0.09"
change="+0.23"
change_from_200_day_moving_average="2.32"
change_from_50_day_moving_average="1.51"
change_from_52_week_high="-0.79"
change_From_52_week_low="6.07"
change_in_percent="+1.72%"
close="13.59"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.56"
ebitda="-52.95M"
eps_estimate_current_year="-0.98"
eps_estimate_next_quarter="-0.24"
eps_estimate_next_year="-0.81"
ex_dividend_date="N/A"
float_shares="94803000"
high="13.90"
high_52_weeks="14.38"
last_trade_date="3/3/2017"
last_trade_price="13.59"
last_trade_size="52694"
last_trade_time="4:00pm"
low="13.30"
low_52_weeks="7.52"
market_capitalization="1.74B"
moving_average_200_day="11.27"
moving_average_50_day="12.08"
name="Halozyme Therapeutics
Inc."
notes="N/A"
one_year_target_price="16.00"
open="13.37"
pe_ratio="N/A"
peg_ratio="0.33"
percent_change_from_200_day_moving_average="+20.54%"
percent_change_from_50_day_moving_average="+12.47%"
percent_change_from_52_week_high="-5.49%"
percent_change_from_52_week_low="+80.72%"
previous_close="13.36"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="10.71"
revenue="159.91M"
shares_outstanding="128154000"
short_ratio="8.07"
stock_exchange="NMS"
symbol="HALO"
volume="1379682"
weeks_range_52="7.52 - 14.38"
